Podcasts about nomogram

Acetaminophen is widely available over the counter in the United States, increasing the risk of overdose (both acute and chronic). Several factors contribute to the complexity of managing this tricky condition in the emergency department, but until recently, there has been no true standardized approach. Guidance issued in 2023 aims to establish a helpful framework for managing acetaminophen overdose.  EMRA*Cast host Kyle Duke, MD, breaks it down with EMRA Toxicology Committee Chair Mason Jackson, MD.

Not long after the release of the Quadrennial Gossipry, a safe-blower is released that can be used to disable safe-blowers without blowing the safe open. George Hotz of course is the first to try it out and unsurprisingly, chaos erupts.

No doubt, you’ve heard someone say that babies lose weight after birth but need to surpass their birth weight by 7 days, or 2 weeks, or 3 weeks. Similarly, you’ve probably heard that babies who have a 10% weight loss in the first few days require formula supplementation. But is this “decaphobia” justified? Join Marie and her guest, clinical pediatrician and expert researcher Dr. Ian Paul, who says that these numbers and assumptions have been based on anecdote, not evidence. Dr. Paul has given us the NEWT, i.e., the nomogram which represents the new and evidence-based standard to understand newborn weight loss. Whether you are a parent or a provider, you’ll learn the who-what-where-when-why of the NEWT, the research from 160,000 babies that propelled its inception, how it compares with expert recommendations, how weight loss in babies born by vaginal compares to cesarean birth, and how 36-weekers compare to 37-weekers. Don’t miss this exciting episode!

Dr Preeya Gupta and Dr. Gary Wortz discuss the importance of managing low levels of corneal astigmatism and how your refractive outcomes rely on this. They review their success with using the femtosecond laser for arcuate incisions, and discuss the in's and out's of a novel Femto LRI nomogram available at www.lricalc.com

We discuss the clinical approach to evaluation and management of neonatal jaundice. We are joined by Jessica Morse, MD, Assistant Professor of Neonatal-Perinatal Medicine at the University of Texas Southwestern Medical Center, and Medical Director of the Parkland Memorial Hospital Newborn Nursery.

No doubt, you’ve heard someone say that babies lose weight after birth but need to surpass their birth weight by 7 days, or 2 weeks, or 3 weeks. Similarly, you’ve probably heard that babies who have a 10% weight loss in the first few days require formula supplementation. But is this “decaphobia” justified? Join Marie and her guest, clinical pediatrician and expert researcher Dr. Ian Paul, who says that these numbers and assumptions have been based on anecdote, not evidence. Dr. Paul has given us the NEWT, i.e., the nomogram which represents the new and evidence-based standard to understand newborn weight loss. Whether you are a parent or a provider, you’ll learn the who-what-where-when-why of the NEWT, the research from 160,000 babies that propelled its inception, how it compares with expert recommendations, how weight loss in babies born by vaginal compares to cesarean birth, and how 36-weekers compare to 37-weekers. Don’t miss this exciting episode!

Sean P. Kane, PharmD, BCPS, speaks with Nadia Awad, PharmD, BCPS about Rumack-Matthew nomogram and acetaminophen toxicity. In the episode, the toxidrome of acetaminophen overdose is outlined and the nuances (including clinical practice pearls) are discussed regarding the nomogram used to decide whether N-acetylcysteine is warranted for acetaminophen toxicity.

Sean P. Kane, PharmD, BCPS, speaks with Nadia Awad, PharmD, BCPS about Rumack-Matthew nomogram and acetaminophen toxicity. In the episode, the toxidrome of acetaminophen overdose is outlined and the nuances (including clinical practice pearls) are discussed regarding the nomogram used to decide whether N-acetylcysteine is warranted for acetaminophen toxicity.

In this podcast, Dr. Hudis reviews the use of a novel nomogram to predict the benefits of postoperative adjuvant radiation therapy for older women with early stage breast cancer. This discussion highlights the information from prospective randomized trials, their limitations, and the potential for a nomogram to guide clinicians facing patients who might not have qualified for the earlier studies.